Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Cirrhosis

Free Subscription 22.09.2025 1 Ann Intern Med 1 BMC Gastroenterol 5 Hepatology 1 PLoS One 2 Transplant Proc 1 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. IMPERIALE TF
   In MASH with moderate or advanced liver fibrosis, weekly semaglutide improved histologic steatohepatitis and fibrosis at 72 wk.
   Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03308.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

2. SEMEYA AA, Hafez RSAA, Ewais SHM, Mostafa SM, et al
   Screening for metabolic-associated fatty liver disease in type 2 diabetes patients using non-invasive scores and ultrasound: a cross-sectional study in Egypt.
   BMC Gastroenterol. 2025;25:639.
   PubMed         Abstract available
   
   

   
   Hepatology

3. DELTENRE P, Marot A, Henrion J
   A prognostic model in patients with alcohol-related cirrhosis does exist.
   Hepatology. 2025 Sep 17. doi: 10.1097/HEP.0000000000001532.
   PubMed        
   
   
4. MOL B, Werner E, Culver EL, van der Meer AJ, et al
   Epidemiological and economical burden of cholestatic liver disease.
   Hepatology. 2025 Apr 1. doi: 10.1097/HEP.0000000000001341.
   PubMed         Abstract available
   
   
5. CANCADO GGL, Deeb M, Gulamhusein AF
   Liver transplantation for cholestatic liver diseases: Timing & disease recurrence.
   Hepatology. 2025 Feb 17. doi: 10.1097/HEP.0000000000001268.
   PubMed         Abstract available
   
   
6. RONCA V, Davies SP, Oo YH, Lleo A, et al
   The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects.
   Hepatology. 2025 Jan 3. doi: 10.1097/HEP.0000000000001225.
   PubMed         Abstract available
   
   
7. LEVY C, Bowlus CL
   Primary Biliary Cholangitis: personalizing second-line therapies.
   Hepatology. 2024 Nov 12. doi: 10.1097/HEP.0000000000001166.
   PubMed         Abstract available
   
   

   
   PLoS One

8. MULLER-KUHNLE J, Schanz M, Schricker S, Benignus C, et al
   Predicting severe renal dysfunction in alcohol-associated cirrhosis: Comparative performance of liver function scores and machine learning models.
   PLoS One. 2025;20:e0332840.
   PubMed         Abstract available
   
   

   
   Transplant Proc

9. HASEGAWA Y, Obara H, Ojiro K, Kitago M, et al
   Trends and Barriers in Liver Transplantation for Patients With Decompensated Cirrhosis: A 15-Year Single-Center Cohort at a Japanese Center.
   Transplant Proc. 2025 Sep 16:S0041-1345(25)00453.
   PubMed         Abstract available
   
   
10. EGELI T, Unek T, Ozbilgin M, Agalar C, et al
    Evaluation of Etiology Based on Post-Transplant Pathological Diagnosis in Cases of Cryptogenic Cirrhosis.
    Transplant Proc. 2025 Sep 16:S0041-1345(25)00384.
    PubMed         Abstract available
    
    

    
    Z Gastroenterol

11. EICHHOLZ JC, Dietz-Fricke C, Mrowietz SK, Dinkelborg K, et al
    Quality of life improves during antiviral therapy with bulevirtide.
    Z Gastroenterol. 2025;63:930-941.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.